Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > if biotech is correct, than submission will definitely be

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon May 12, 2020 9:58am

73 Views

Post# 31016215

RE:RE:RE:if biotech is correct, than submission will definitely be

Yes Newcamo, H1 ends June 30 not June 1. Exactly what I posted and glad I could educate you and Biotech.

Biotech posted 15 business days left? ROF

Who would ever take advice from you.

GunnerG wrote: Newcamo, one month now two months. LMAO

Then Biotech, omg. Expect a delay in filing, complete the paper work and get it in. F--K, its been nine months since finishing additional processes. What does how busy FDA is to handing the paperwork in.

What is technically 15 business days left? LOL H1 ends June 30 not June 1.